CytomX Therapeutics, Inc. Business Operations Contracts & Agreements

17 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amendment No. 3 to the Collaboration and License Agreement, dated as of May 18, 2023, by and between CytomX Therapeutics, Inc. and Amgen, Inc
Collaboration Agreements
CytomX Therapeutics, Inc.
Biotechnology
NY
2023
Amendment No 3 to Collaboration and License Agreement, dated May 23, 2014, by and between the Company and Bristol Myers Squibb Company, effective as of October 11, 2022
Collaboration Agreements
CytomX Therapeutics, Inc.
Biotechnology
2022
Amendment No. 2 to the Collaboration and License Agreement, dated as of October 27, 2021, by and between CytomX Therapeutics, Inc. and Amgen, Inc
Collaboration Agreements
CytomX Therapeutics, Inc.
Biotechnology
NY
2022
Amendment No 2 to Collaboration and License Agreement, as amended, dated March 17, 2017, by and between the Company and Bristol Myers Squibb, effective as of February 22, 2021
Collaboration Agreements
CytomX Therapeutics, Inc.
Biotechnology
2021
Amendment No. 1 to the Collaboration and License Agreement, dated as of September 29, 2020, by and between CytomX Therapeutics, Inc. and Amgen, Inc
Collaboration Agreements
CytomX Therapeutics, Inc.
Biotechnology
NY
2020
Collaboration and License Agreement dated as of May 23, 2014, by and between CytomX Therapeutics, Inc. and Bristol-Myers Squibb Company
Collaboration Agreements
CytomX Therapeutics, Inc.
Biotechnology
NJ
2020
Research Collaboration, Option and License Agreement dated as of May 30, 2013, by and between CytomX Therapeutics, Inc. and Pfizer, Inc
Collaboration Agreements
CytomX Therapeutics, Inc.
Biotechnology
NY
2020
Collaboration and License Agreement dated as of March 23, 2020, by and between CytomX Therapeutics, Inc. and Astellas Pharma Inc
Collaboration Agreements
CytomX Therapeutics, Inc.
Biotechnology
NY
2020
Amended and Restated Discovery Collaboration and License Agreement, dated as of June 28, 2019, by and between CytomX Therapeutics, Inc., and AbbVie Ireland Unlimited Company
Collaboration Agreements
CytomX Therapeutics, Inc.
Biotechnology
DE
2019
Third Amendment to the Research Collaboration Agreement by and between CytomX Therapeutics, Inc. and ImmunoGen Inc., dated as of March 3, 2017
Collaboration Agreements
CytomX Therapeutics, Inc.
Biotechnology
2018
Second Amendment to the Research Collaboration Agreement by and between CytomX Therapeutics, Inc. and ImmunoGen Inc., dated as of February 12,2016
Collaboration Agreements
CytomX Therapeutics, Inc.
Biotechnology
2018
Collaboration and License Agreement by and between CytomX Therapeutics, Inc. and Amgen, Inc. dated as of September 29, 2017
Collaboration Agreements
CytomX Therapeutics, Inc.
Biotechnology
NY
2017
AMENDMENT NUMER 1 TO EXTEND COLLABORATION AND LICENSE AGREEMENT
Collaboration Agreements
CytomX Therapeutics, Inc.
Biotechnology
2017
RESEARCH COLLABORATION, OPTION AND LICENSE AGREEMENT BY AND BETWEEN PFIZERINC. AND CYTOMX THERAPEUTICS, INC. MAY 30, 2013
Collaboration Agreements
CytomX Therapeutics, Inc.
Biotechnology
DE
2015
COLLABORATION AND LICENSE AGREEMENT
Collaboration Agreements
CytomX Therapeutics, Inc.
Biotechnology
NJ
2015
RESEARCH COLLABORATION AGREEMENT BETWEEN CYTOMXTHERAPEUTICS, INC. AND IMMUNOGEN, INC. JANUARY 8, 2014
Collaboration Agreements
CytomX Therapeutics, Inc.
Biotechnology
DE
2015
INDEMNIFICATION AGREEMENT
Indemnification Agreements
CytomX Therapeutics, Inc.
Biotechnology
DE
2015